Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis.
Spałek MJ, Poleszczuk J, Czarnecka AM, Dudzisz-Śledź M, Napieralska A, Matysiakiewicz J, Chojnacka M, Raciborska A, Sztuder A, Maciejczyk A, Szulc A, Skóra T, Cybulska-Stopa B, Winiecki T, Kaźmierska J, Tomasik B, Fijuth J, Rutkowski P. Spałek MJ, et al. Among authors: czarnecka am. Cells. 2021 Feb 10;10(2):366. doi: 10.3390/cells10020366. Cells. 2021. PMID: 33578676 Free PMC article.
High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.
Teterycz P, Jagodzińska-Mucha P, Cybulska-Stopa B, Mariuk-Jarema A, Kozak K, Koseła-Paterczyk H, Czarnecka AM, Rajczykowski M, Dziura R, Galus Ł, Mackiewicz J, Świtaj T, Klimczak A, Falkowski S, Suwiński R, Ziobro M, Ługowska I, Rutkowski P. Teterycz P, et al. Among authors: czarnecka am. Melanoma Res. 2018 Oct;28(5):435-441. doi: 10.1097/CMR.0000000000000461. Melanoma Res. 2018. PMID: 29782381
Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure.
Sobczuk P, Teterycz P, Lugowska I, Klimczak A, Bylina E, Czarnecka AM, Kosela-Paterczyk H, Osuch C, Streb J, Rutkowski P. Sobczuk P, et al. Among authors: czarnecka am. Oncol Lett. 2019 Sep;18(3):3373-3380. doi: 10.3892/ol.2019.10622. Epub 2019 Jul 16. Oncol Lett. 2019. PMID: 31452817 Free PMC article.
Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence.
Cybulska-Stopa B, Rogala P, Czarnecka AM, Ługowska I, Teterycz P, Galus Ł, Rajczykowski M, Dawidowska A, Piejko K, Suwiński R, Mackiewicz J, Rutkowski P. Cybulska-Stopa B, et al. Among authors: czarnecka am. Adv Med Sci. 2020 Sep;65(2):316-323. doi: 10.1016/j.advms.2020.05.005. Epub 2020 Jun 15. Adv Med Sci. 2020. PMID: 32554313
Targeted Therapy in Melanoma and Mechanisms of Resistance.
Czarnecka AM, Bartnik E, Fiedorowicz M, Rutkowski P. Czarnecka AM, et al. Int J Mol Sci. 2020 Jun 27;21(13):4576. doi: 10.3390/ijms21134576. Int J Mol Sci. 2020. PMID: 32605090 Free PMC article. Review.
Mutation profile of primary subungual melanomas in Caucasians.
Borkowska A, Szumera-Ciećkiewicz A, Spałek M, Teterycz P, Czarnecka A, Kowalik A, Rutkowski P. Borkowska A, et al. Oncotarget. 2020 Jun 23;11(25):2404-2413. doi: 10.18632/oncotarget.27642. eCollection 2020 Jun 23. Oncotarget. 2020. PMID: 32637031 Free PMC article.
176 results